Rituximab pharmacokinetics in ascites and serum in the treatment of follicular lymphoma with massive ascites

Annals of Hematology

Volumn 91, Issue 9, 2012, Pages 1499-1500

  Hiroshima, Yuki ^a   Tajima, Katsushi ^a   Shiono, Yousuke ^a   Suzuki, Ikuko ^a   Kouno, Kei ^a   Yamamoto, Masakazu ^a   Kato, Yuichi ^a   Kato, Takeo ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE;

ABDOMINAL DISCOMFORT; ADULT; ASCITES; ASCITES FLUID LEVEL; B CELL LYMPHOMA; CASE REPORT; CHROMOSOME ABERRATION; DRUG BLOOD LEVEL; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETTER; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL;

ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASCITES; CYCLOPHOSPHAMIDE; DOXORUBICIN; HUMANS; LYMPHOMA, FOLLICULAR; MALE; PREDNISONE; RECURRENCE; REMISSION INDUCTION; VINCRISTINE;

EID: 84864944675     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-012-1410-9     Document Type: Letter

References (5)

1. Berinstein NL, Grillo-Lopez AJ, White CA, Bence-Brucker I,Maloney D, Czuczman M, Green D, Rosenberg J, McLaughlin P, Shen D (1998) Association of serum rituximab (IDEC-C2B8) concentration and antitumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma. Ann Oncol 9:995-1001
2. Ng T, Pagliuca A, Mufti GJ (2002) Intraperitoneal rituximab: an effective measure to control recurrent abdominal ascites due to non-Hodgkin's lymphoma. Ann Hematol 81:405-406
3. Schmidt HH, Renner H, Linkesch W (2004) Intrapleural instillation of rituximab for the treatment of malignant pleural effusions in NHL. Hematologica 89:133-134
4. Crysandt M, Neumann B, Das M, Engelbertz V, Bendel M, Galm O, Osieka R, Jost E (2007) Intraperitoneal application of rituximab in refractory mantle cell lymphoma with massive ascites resulting in local and systemic response. Eur J Haematol 79:546-549
5. Flieger D, Renoth S, Beier I, Sauerbruch T,Wolf IS (2000)Mechanism of cytotoxicity induced by chimeric mouse monoclonal antibody IDEC-C2B8 in CD20-expressing lymphoma cell lines. Cell Immunol 204:55-63